Michigan's Regulatory Gauntlet: Navigating Telehealth, Medspas, and CPOM in the Wolverine State
Back to Blog
State SpotlightApril 17, 2026

Michigan's Regulatory Gauntlet: Navigating Telehealth, Medspas, and CPOM in the Wolverine State

Michigan presents a complex, yet fertile, ground for healthcare innovation. However, its robust regulatory framework, particularly concerning telehealth, medspas, and the Corporate Practice of Medicine, demands meticulous compliance. This deep dive provides a critical roadmap for navigating the Wolverine State's unique compliance challenges.

9 min read8 views

The healthcare landscape in Michigan is characterized by a dynamic interplay of innovation and stringent regulatory oversight. For telehealth founders, medspa operators, and brick-and-mortar practices looking to expand, understanding Michigan's specific legal environment is not merely advisable—it is absolutely essential for sustainable operations. The state's regulatory bodies, particularly the Michigan Board of Medicine, have demonstrated a clear and increasing focus on compliance, making proactive risk mitigation a top priority.

For more on this topic, see our analysis: Michigan's Regulatory Crossroads: Navigating Telehealth, Medspas, and CPOM in the Wolverine State.

Corporate Practice of Medicine (CPOM) in Michigan: A Nuanced Approach

Unlike some states with explicit statutory prohibitions or strict enforcement, Michigan's Corporate Practice of Medicine (CPOM) doctrine is largely derived from common law and various professional practice acts. While there isn't a single, overarching statute explicitly banning CPOM, the spirit of the doctrine is upheld through regulations that prohibit unlicensed individuals or entities from practicing medicine or controlling medical decision-making.

For more on this topic, see our analysis: Michigan's Regulatory Crossroads: Navigating Telehealth, Medspas, and CPOM in the Wolverine State.

This means that while a non-physician owned entity can provide administrative services to a medical practice, it cannot employ physicians, control clinical judgments, or engage in fee-splitting arrangements that undermine professional independence. The Michigan Board of Medicine (MBOM) and other professional boards consistently emphasize that the patient-physician relationship must remain unencumbered by commercial interests.

For telehealth brands, this translates to a critical need for compliant structuring. Direct employment of Michigan-licensed physicians by a national, non-professional corporation is generally problematic. Instead, models involving Management Service Organizations (MSOs) providing administrative support to physician-owned professional corporations (PCs) or professional limited liability companies (PLLCs) are the preferred path. The MSO agreement must be meticulously drafted to ensure fair market value compensation for services, clearly delineate administrative from clinical responsibilities, and explicitly state that the MSO has no control over medical decisions, hiring/firing of clinical staff, or setting of professional fees. Any deviation risks accusations of illegal fee-splitting or unlicensed practice of medicine.

Medspas in Michigan face similar scrutiny. Services that constitute the practice of medicine (e.g., injectables, laser treatments, certain chemical peels) must be performed by or under the direct supervision of a licensed physician, Physician Assistant (PA), or Nurse Practitioner (NP) operating within their scope of practice. The entity providing these medical services must be professionally owned. Non-physician ownership of a medspa that delivers medical services is a significant CPOM risk. The medical director's role cannot be merely titular; they must be actively engaged, providing appropriate supervision, and maintaining ultimate responsibility for patient care, as highlighted by recent MBOM enforcement trends.

Telehealth-Specific Regulations and Recent Changes

Michigan has embraced telehealth, but with clear guardrails. The state's Public Health Code (MCL 333.16284) and subsequent administrative rules govern telehealth services. Key aspects include:

  • Establishment of Patient-Provider Relationship: Michigan generally requires a valid patient-provider relationship to be established before telehealth services can be rendered. This typically means an initial in-person evaluation or an evaluation via real-time, interactive audio-visual technology. Audio-only consultations may be permissible for established patients or certain follow-up care, but are generally insufficient for initiating a new course of treatment or prescribing controlled substances.
  • Standard of Care: Telehealth services must meet the same standard of care as in-person services. This implies thorough assessments, appropriate documentation, and adherence to professional practice guidelines.
  • Informed Consent: Patients must provide informed consent for telehealth services, which should include information about the technology used, privacy risks, and emergency procedures.
  • Prescribing: Prescribing via telehealth is permitted, but with significant restrictions, particularly for controlled substances (discussed below).
  • Licensure: Providers must be licensed in Michigan to provide telehealth services to patients located in Michigan, even if the provider is physically located in another state. There are no broad interstate compacts that permit out-of-state licensure for all professions.

The COVID-19 Public Health Emergency (PHE) brought temporary flexibilities, but many of these have either expired or are in the process of being formalized. Healthcare businesses must not rely on outdated PHE waivers and should ensure their current operations align with the permanent regulatory framework. The Michigan Board of Medicine's increased scrutiny of telehealth operations, as noted in recent intelligence, underscores the importance of robust compliance in this area.

Medical Board Requirements for Telehealth Providers

The Michigan Board of Medicine (MBOM) and other professional licensing boards (e.g., Board of Nursing, Board of Osteopathic Medicine and Surgery) are actively monitoring telehealth practices. Their requirements for telehealth providers include:

  • Full Michigan Licensure: As stated, providers must hold a current, unrestricted Michigan license relevant to their profession.
  • Competence and Training: Providers are expected to be competent in the use of telehealth technology and to understand its limitations. They must ensure the technology used is HIPAA-compliant and secure.
  • Documentation: Comprehensive documentation of all telehealth encounters, including patient identification, informed consent, assessment, diagnosis, treatment plan, and follow-up, is mandatory.
  • Patient Identification: Robust processes for verifying patient identity and location are crucial to ensure care is delivered to the correct individual and within Michigan's jurisdiction.
  • Emergency Protocols: Providers must have clear protocols for managing emergencies that may arise during a telehealth encounter, including how to connect the patient to local emergency services.

Recent enforcement trends indicate that the MBOM is particularly focused on issues such as unprofessional conduct, scope of practice violations, and inadequate supervision within telehealth settings. This means that merely having a Michigan license is not enough; providers must practice responsibly and ethically within the bounds of their license and state regulations.

Collaborative Practice and Supervision Requirements

Michigan has specific requirements for collaborative practice and supervision, which are particularly relevant for medspas and practices employing Physician Assistants (PAs) and Nurse Practitioners (NPs).

  • Physician Assistants (PAs): PAs in Michigan operate under a practice agreement with a supervising physician. This agreement must outline the scope of practice, delegation of medical tasks, and supervision requirements. While the degree of direct, on-site supervision has evolved, the supervising physician remains ultimately responsible for the PA's actions. For medspas, this means a physician must be actively involved in the PA's practice, reviewing charts, and providing oversight, especially for delegated medical procedures.
  • Nurse Practitioners (NPs) / Advanced Practice Registered Nurses (APRNs): Michigan NPs operate under a collaborative practice agreement with a physician. This agreement defines the scope of practice and the nature of the collaborative relationship. While NPs have a broader scope than PAs, the physician collaborator plays a crucial role in ensuring appropriate medical oversight. For medspas, NPs can perform many aesthetic medical procedures, but their practice must align with their collaborative agreement and the physician's oversight.
  • Delegation: Physicians can delegate certain medical tasks to qualified personnel, but this delegation must be appropriate for the individual's training and licensure, and the physician retains ultimate responsibility. Improper delegation or supervision is a significant area of enforcement risk, especially in medspa settings where non-licensed personnel may perform procedures beyond their legal scope.

Controlled Substance Prescribing Rules

Michigan's rules for prescribing controlled substances are stringent and have been further complicated by evolving federal DEA guidelines. The Michigan Public Health Code (MCL 333.7333) and administrative rules govern controlled substance prescribing.

  • Telehealth and Controlled Substances: While Michigan generally permits prescribing controlled substances via telehealth, it often requires an initial in-person evaluation to establish a legitimate medical purpose, particularly for Schedule II medications. The federal Ryan Haight Act, which generally requires an in-person medical evaluation for controlled substance prescribing via the internet, is paramount here. While COVID-19 PHE waivers temporarily relaxed this, the DEA's proposed rules indicate a return to stricter requirements, likely necessitating an initial in-person visit or a referral from a practitioner who has conducted one for new buprenorphine patients and other Schedule II-V controlled substances. Telehealth providers must stay abreast of these federal changes, as they directly impact state practice.
  • Michigan Automated Prescription System (MAPS): Prescribers are required to check the MAPS database before prescribing Schedule 2-5 controlled substances to identify potential drug-seeking behavior and ensure patient safety.
  • Pain Management: Michigan has specific rules for prescribing opioids for acute and chronic pain, including quantity limits, mandatory counseling, and written agreements for long-term therapy.
  • DEA Registration: Providers prescribing controlled substances must hold a valid DEA registration and be licensed in Michigan. For multi-state telehealth operations, this means obtaining a DEA registration for each state where they prescribe controlled substances, if required by federal or state law.

The DOJ's intensified enforcement against telehealth controlled substance prescribing violations (as noted in the regulatory intelligence) means that Michigan providers must be exceptionally diligent. The 'legitimate medical purpose' standard is critical, and practices must have robust protocols to ensure every prescription is medically necessary and appropriately documented.

State-Specific Licensing and Registration Requirements

Beyond professional licensure, healthcare businesses in Michigan may encounter additional registration requirements:

  • Facility Licensing: Depending on the services offered, certain facilities (e.g., ambulatory surgical centers, freestanding emergency departments) require specific state licensing.
  • Business Registration: All businesses operating in Michigan, including healthcare entities, must register with the Michigan Department of Licensing and Regulatory Affairs (LARA) and comply with corporate filing requirements.
  • Professional Entity Formation: As discussed under CPOM, professional corporations (PCs) or professional limited liability companies (PLLCs) are often required for entities providing medical services, owned by licensed professionals.

Recent Enforcement Actions or Notable Cases

The Michigan Board of Medicine and other professional boards have been increasingly active in enforcement. While specific case names are often confidential, trends indicate a focus on:

  • Telehealth Misconduct: Actions against providers for prescribing without a proper patient-provider relationship, inadequate documentation, or practicing across state lines without a Michigan license.
  • Medspa Violations: Cases involving non-physician ownership, improper delegation of medical procedures to unlicensed staff, inadequate physician supervision, and misrepresentation of services.
  • Opioid Prescribing Issues: Disciplinary actions for overprescribing, failure to check MAPS, or prescribing without a legitimate medical purpose.
  • Unprofessional Conduct: Broad actions related to ethical breaches, patient safety concerns, or violations of professional standards.

These enforcement trends serve as a stark reminder that regulatory compliance is an ongoing, critical responsibility in Michigan. The MBOM's increased scrutiny of telehealth and medspa services signals a critical need for robust compliance frameworks within these sectors.

Key Compliance Pitfalls and How to Avoid Them

  1. Ignoring CPOM: Assuming a national corporate structure is compliant in Michigan without specific legal review. Solution: Structure your practice as a physician-owned professional entity, supported by a meticulously drafted MSO agreement that respects clinical independence.
  2. Inadequate Telehealth Patient-Provider Relationship: Prescribing or treating new patients via audio-only or without a proper initial real-time audio-visual evaluation. Solution: Implement strict protocols requiring a valid, Michigan-compliant patient-provider relationship for all telehealth services, especially for initial encounters and controlled substance prescribing.
  3. Insufficient Supervision in Medspas: Medical directors acting as mere figureheads or delegating procedures beyond the scope of practice of their staff. Solution: Ensure active, engaged medical directorship with appropriate oversight, training, and documentation of supervision for all delegated medical procedures.
  4. Non-Compliance with Controlled Substance Rules: Failing to check MAPS, not adhering to federal Ryan Haight Act requirements for telehealth prescribing, or prescribing without a clear legitimate medical purpose. Solution: Implement robust internal policies, train providers on federal and state controlled substance laws, and conduct regular audits of prescribing practices.
  5. Practicing Without Proper Licensure: Providers treating Michigan patients without a Michigan license. Solution: Verify all providers hold active, unrestricted Michigan licenses for their respective professions.

Comparison with Neighboring States

Michigan's regulatory environment shares some similarities but also distinct differences from its neighbors. For instance:

  • Ohio: Ohio also has a form of CPOM, but its telehealth laws are generally considered progressive, with a clear framework for establishing patient-provider relationships and prescribing. However, like Michigan, it emphasizes the standard of care and proper licensure.
  • Indiana: Indiana has a less stringent CPOM doctrine than Michigan, often allowing for more corporate ownership of medical practices, though professional independence is still valued. Its telehealth laws are also evolving, with a focus on parity.
  • Wisconsin: Wisconsin's CPOM is also primarily common law-based, similar to Michigan, requiring careful structuring. Telehealth regulations are generally aligned with national trends but with state-specific nuances on consent and documentation.

Each state presents its own set of challenges, underscoring the need for state-specific legal counsel when expanding operations. What works in one state may be a significant compliance risk in Michigan.

What This Means For Your Practice

Operating in Michigan's healthcare sector demands a sophisticated understanding of its regulatory framework. For telehealth brands, this means meticulously structuring your legal entities to comply with CPOM, ensuring all providers are Michigan-licensed, and adhering to strict telehealth prescribing rules, especially for controlled substances. Your technology must facilitate compliant patient-provider relationships and robust documentation.

For medspa operators, the focus must be on legitimate medical directorship, proper delegation, and ensuring that all medical services are rendered by licensed professionals within a CPOM-compliant structure. Misrepresentation or inadequate supervision will draw regulatory attention.

For dental, chiropractic, and wellness practices, any expansion into adjunctive services or telehealth must strictly adhere to your specific professional board's scope of practice, supervision, and telehealth guidelines. The Michigan Public Health Code and administrative rules are your primary guide.

Proactive compliance is not an option; it's a necessity. Regular internal audits, comprehensive staff training, and ongoing legal counsel specializing in Michigan healthcare law are indispensable. The Michigan Board of Medicine's vigilance is a clear signal: businesses must prioritize regulatory adherence to thrive in this complex, yet opportunity-rich, state. TrueEval stands ready to help you navigate these complexities, ensuring your operations are not just innovative, but impeccably compliant.


Further Reading

MichiganTelehealth ComplianceMedspa RegulationsCPOMControlled SubstancesMedical Board Enforcement

Enjoyed this article?

Get our bi-weekly compliance digest delivered straight to your inbox. Join healthcare leaders staying ahead of regulatory changes.